Australia Implantable Cardioverter Defibrillators Market Size & Outlook
Australia implantable cardioverter defibrillators market, 2018-2030 (US$M)
Related Markets
Australia implantable cardioverter defibrillators market highlights
- The Australia implantable cardioverter defibrillators market generated a revenue of USD 96.4 million in 2023 and is expected to reach USD 172.4 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, transvenous implantable cardioverter-defibrillators was the largest revenue generating product in 2023.
- Subcutaneous Implantable Cardioverter Defibrillators is the most lucrative product segment registering the fastest growth during the forecast period.
Implantable cardioverter defibrillators market data book summary
| Market revenue in 2023 | USD 96.4 million |
| Market revenue in 2030 | USD 172.4 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Transvenous implantable cardioverter-defibrillators |
| Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
Other key industry trends
- In terms of revenue, Australia accounted for 2.5% of the global implantable cardioverter defibrillators market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan implantable cardioverter defibrillators market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 210.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardioverter Defibrillators Market Scope
Implantable Cardioverter Defibrillators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia implantable cardioverter defibrillators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.73% in 2023. Horizon Databook has segmented the Australia implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of heart diseases in Australia is quite high, around 1 million people were diagnosed with heart conditions, such as angina, heart attacks, and strokes, from 2020 to 2021. This high incidence of heart disease is expected to improve the demand for effective treatments like ICDs.
The government in Australia actively supports the advancement of cardiovascular devices by providing financial assistance to accelerate clinical trials. For instance, in February 2021, a grant of USD 200,000 was awarded to the Australian Cardiovascular Alliance (ACvA) to enhance Australia’s involvement in these trials.
In addition, the Victor Chang Cardiac Research Institute and the Charles Perkins Centre at the University of Sydney play pivotal roles in overseeing these trials. Through their collaborative efforts in research and development within the cardiovascular field, they aim to expedite the availability of these devices, contributing to the growth of the ICD market in Australia.
Reasons to subscribe to Australia implantable cardioverter defibrillators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia implantable cardioverter defibrillators market databook
-
Our clientele includes a mix of implantable cardioverter defibrillators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Australia implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia implantable cardioverter defibrillators market size, by product, 2018-2030 (US$M)
Australia Implantable Cardioverter Defibrillators Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
